REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
Author
Summary, in English
The androgen receptor (AR) is a key regulator of prostate tumorgenesis through actions that are not fully understood. We identified the repressor element (RE)-1 silencing transcription factor (REST) as a mediator of AR actions on gene repression. Chromatin immunoprecipitation showed that AR binds chromatin regions containing well-characterized cis-elements known to mediate REST transcriptional repression, while cell imaging studies confirmed that REST and AR closely co-localize in vivo. Androgen-induced gene repression also involves modulation of REST protein turnover through actions on the ubiquitin ligase β-TRCP. Androgen deprivation or AR blockage with inhibitor MDV3100 (Enzalutamide) leads to neuroendocrine (NE) differentiation, a phenomenon that is mimicked by REST inactivation. Gene expression profiling revealed that REST not only acts to repress neuronal genes but also genes involved in cell cycle progression, including Aurora Kinase A, that has previously been implicated in the growth of NE-like castration-resistant tumors. The analysis of prostate cancer tissue microarrays revealed that tumors with reduced expression of REST have higher probability of early recurrence, independently of their Gleason score. The demonstration that REST modulates AR actions in prostate epithelia and that REST expression is negatively correlated with disease recurrence after prostatectomy, invite a deeper characterization of its role in prostate carcinogenesis.
Department/s
- Urological research, Malmö
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Urological cancer, Malmö
- Pathology, Malmö
- EpiHealth: Epidemiology for Health
Publishing year
2014
Language
English
Pages
999-1015
Publication/Series
Nucleic Acids Research
Volume
42
Issue
2
Full text
- Available as PDF - 12 MB
- Download statistics
Links
Document type
Journal article
Publisher
Oxford University Press
Topic
- Cell and Molecular Biology
Status
Published
Research group
- Urological research, Malmö
- Urological cancer, Malmö
- Pathology, Malmö
ISBN/ISSN/Other
- ISSN: 1362-4962